Physician

Kathryn R Chan, MD

According to 2025 Medicare claims, Kathryn Chan, MD (NPI: 1588698369) practices internal medicine in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is NEXUS HEALTH (NPI: 1801516489; TIN: 87-3699084) and primary practice location at 87507-9998.

Chan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 446 traditional Medicare patients, billed 87,895 HCPCS/CPT codes, and received $1,900,330 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,345 prescription claims across 244 beneficiaries totaling $4,727,544 in drug costs, led by Ibrance (Palbociclib). DME data shows 31 claims. Open Payments data shows 81 records totaling $1,566. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $86,074 to $1,900,330. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $938,173 to $4,727,544. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,949 and ending at $2,894.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	412	7,315	$86,074
2016	394	2,185	$119,943
2017	435	1,834	$179,287
2018	489	2,013	$201,309
2019	462	1,937	$198,011
2020	422	1,958	$214,518
2021	387	1,769	$195,747
2022	368	1,306	$113,040
2023	377	62,243	$1,547,289
2024	446	87,895	$1,900,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	739	$938,173
2016	193	944	$1,815,258
2017	170	769	$1,714,377
2018	197	909	$1,933,753
2019	191	936	$2,641,832
2020	196	1,052	$3,004,960
2021	200	1,097	$3,197,702
2022	211	995	$3,165,413
2023	209	1,003	$4,174,047
2024	244	1,345	$4,727,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	38	$26,396
2016	N/R	15	$1,094
2017	N/R	54	$14,347
2018	N/R	61	$7,434
2019	N/R	27	$2,228
2020	N/R	52	$3,073
2021	N/R	50	$4,357
2022	N/R	38	$3,535
2023	N/R	32	$3,567
2024	N/R	31	$2,851

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	83	162	$134
96413	Administration of chemotherapy into vein, 1 hour or less	88	214	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	175	360	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	165	234	$65
96375	Injection of additional new drug or substance into vein	78	525	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	59	1,876	$998,569
Cabometyx	Cabozantinib S-Malate	17	870	$739,887
Calquence	Acalabrutinib Maleate	23	690	$272,569
Lynparza	Olaparib	14	420	$236,962
Imbruvica	Ibrutinib	13	364	$209,182

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$2,851

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	81	$1,566	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kathryn R. Chan, MD?

Tedicare shows public-source Medicare data for Kathryn R. Chan, MD (NPI 1588698369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kathryn R. Chan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kathryn R. Chan, MD?

Kathryn R. Chan, MD is linked to NEXUS HEALTH (billing NPI 1801516489) in the available physician profile data.

Does Kathryn R. Chan, MD have Open Payments data?

Kathryn R. Chan, MD has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.